| Classification of metal-based drugs according to their mechanisms of action E Boros, PJ Dyson, G Gasser Chem 6 (1), 41-60, 2020 | 269 | 2020 |
| Radioactive transition metals for imaging and therapy E Boros, AB Packard Chemical reviews 119 (2), 870-901, 2018 | 232 | 2018 |
| Acyclic Chelate with Ideal Properties for 68Ga PET Imaging Agent Elaboration E Boros, CL Ferreira, JF Cawthray, EW Price, BO Patrick, DW Wester, ... Journal of the American Chemical Society 132 (44), 15726-15733, 2010 | 180 | 2010 |
| In vitro anticancer activity and in vivo biodistribution of rhenium (I) tricarbonyl aqua complexes KM Knopf, BL Murphy, SN MacMillan, JM Baskin, MP Barr, E Boros, ... Journal of the American Chemical Society 139 (40), 14302-14314, 2017 | 168 | 2017 |
| MR imaging probes: design and applications E Boros, EM Gale, P Caravan Dalton transactions 44 (11), 4804-4818, 2015 | 137 | 2015 |
| Chelate-free metal ion binding and heat-induced radiolabeling of iron oxide nanoparticles E Boros, AM Bowen, L Josephson, N Vasdev, JP Holland Chemical science 6 (1), 225-236, 2015 | 131 | 2015 |
| H4octapa: An Acyclic Chelator for 111In Radiopharmaceuticals EW Price, JF Cawthray, GA Bailey, CL Ferreira, E Boros, MJ Adam, ... Journal of the American Chemical Society 134 (20), 8670-8683, 2012 | 126 | 2012 |
| Gd (DOTAla): a single amino acid Gd-complex as a modular tool for high relaxivity MR contrast agent development E Boros, M Polasek, Z Zhang, P Caravan Journal of the American Chemical Society 134 (48), 19858-19868, 2012 | 93 | 2012 |
| RGD conjugates of the H2dedpa scaffold: synthesis, labeling and imaging with 68Ga E Boros, CL Ferreira, DTT Yapp, RK Gill, EW Price, MJ Adam, C Orvig Nuclear medicine and biology 39 (6), 785-794, 2012 | 92 | 2012 |
| H2azapa: a Versatile Acyclic Multifunctional Chelator for 67Ga, 64Cu, 111In, and 177Lu GA Bailey, EW Price, BM Zeglis, CL Ferreira, E Boros, MJ Lacasse, ... Inorganic chemistry 51 (22), 12575-12589, 2012 | 78 | 2012 |
| H2CHXdedpa and H4CHXoctapaChiral Acyclic Chelating Ligands for 67/68Ga and 111In Radiopharmaceuticals CF Ramogida, JF Cawthray, E Boros, CL Ferreira, BO Patrick, MJ Adam, ... Inorganic Chemistry 54 (4), 2017-2031, 2015 | 73 | 2015 |
| Macrocycle‐Based Hydroxamate Ligands for Complexation and Immunoconjugation of 89Zirconium for Positron Emission Tomography (PET) Imaging E Boros, JP Holland, N Kenton, N Rotile, P Caravan ChemPlusChem 81 (3), 274-281, 2016 | 71 | 2016 |
| Evaluation of the H2dedpa Scaffold and its cRGDyK Conjugates for Labeling with 64Cu E Boros, JF Cawthray, CL Ferreira, BO Patrick, MJ Adam, C Orvig Inorganic Chemistry 51 (11), 6279-6284, 2012 | 64 | 2012 |
| Theranostic gallium siderophore ciprofloxacin conjugate with broad spectrum antibiotic potency A Pandey, C Savino, SH Ahn, Z Yang, SG Van Lanen, E Boros Journal of medicinal chemistry 62 (21), 9947-9960, 2019 | 63 | 2019 |
| 68Ga Small Peptide Imaging: Comparison of NOTA and PCTA CL Ferreira, DTT Yapp, D Mandel, RK Gill, E Boros, MQ Wong, P Jurek, ... Bioconjugate Chemistry 23 (11), 2239-2246, 2012 | 61 | 2012 |
| Bioorthogonal Fluorophore Linked DFO Technology Enabling Facile Chelator Quantification and Multimodal Imaging of Antibodies LG Meimetis, E Boros, JC Carlson, C Ran, P Caravan, R Weissleder Bioconjugate chemistry 27 (1), 257-263, 2016 | 60 | 2016 |
| Chemical aspects of metal ion chelation in the synthesis and application antibody‐based radiotracers E Boros, JP Holland Journal of Labelled Compounds and Radiopharmaceuticals 61 (9), 652-671, 2018 | 58 | 2018 |
| Establishing radiolanthanum chemistry for targeted nuclear medicine applications E Aluicio‐Sarduy, NA Thiele, KE Martin, BA Vaughn, J Devaraj, AP Olson, ... Chemistry–A European Journal 26 (6), 1238-1242, 2020 | 55 | 2020 |
| Combinatorial synthesis to identify a potent, necrosis-inducing rhenium anticancer agent CC Konkankit, BA Vaughn, SN MacMillan, E Boros, JJ Wilson Inorganic Chemistry 58 (6), 3895-3909, 2019 | 51 | 2019 |
| Multifunctional Desferrichrome Analogues as Versatile 89Zr(IV) Chelators for ImmunoPET Probe Development CJ Adams, JJ Wilson, E Boros Molecular pharmaceutics 14 (8), 2831-2842, 2017 | 51 | 2017 |
